EssilorLuxottica S.A. Unsponsored ADR logo

EssilorLuxottica S.A. Unsponsored ADR (ESLOY)

Market Closed
30 Jul, 20:00
OTC PINK OTC PINK
$
94. 60
+1.01
+1.0792%
$
85.06B Market Cap
35.05 P/E Ratio
4.69% Div Yield
8,938 Volume
0 Eps
$ 93.59
Previous Close
Investors:
Add Transaction
Day Range
93.73 95.25
Year Range
91.44 186.81
Want to track ESLOY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Meta's metaverse vision trained on Ray-Ban owner EssilorLuxottica stake

Meta's metaverse vision trained on Ray-Ban owner EssilorLuxottica stake

Facebook, Threads, Instagram and WhatsApp parent Meta Platforms Inc (NASDAQ:META, ETR:FB2A, SWX:FB) is in discussions with EssilorLuxottica to acquire a 5% stake in the Ray-Bans owner. If a Bloomberg report citing “people familiar with the matter” proves accurate, it would amount to a nearly $5 billion stake in the Franco-Italian eyewear corporation.

Proactiveinvestors | 2 years ago
Meta in Talks to Buy Stake in Eyewear Giant EssilorLuxottica

Meta in Talks to Buy Stake in Eyewear Giant EssilorLuxottica

Facebook parent Meta Platforms META -5.68%decrease; red down pointing triangle is in talks to acquire a stake of about 5% in eyewear giant EssilorLuxottica EL 6.14%increase; green up pointing triangle, the company it partners with to make its Ray-Ban smart glasses, according to people familiar with the matter.

Wsj | 2 years ago
Meta explores stake in Ray-Ban maker EssilorLuxottica, FT reports

Meta explores stake in Ray-Ban maker EssilorLuxottica, FT reports

Meta Platforms has explored a multibillion-euro investment in eyewear group EssilorLuxottica , the Financial Times reported on Thursday.

Reuters | 2 years ago
ESLOY vs. PODD: Which Stock Is the Better Value Option?

ESLOY vs. PODD: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Products sector have probably already heard of EssilorLuxottica Unsponsored ADR (ESLOY) and Insulet (PODD). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 2 years ago